Cargando…

Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications

Introduction: European countries need to learn from each other to address unsustainable increases in pharmaceutical expenditures. Objective: To assess the influence of the many supply and demand-side initiatives introduced across Europe to enhance prescribing efficiency in ambulatory care. As a resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Godman, Brian, Shrank, William, Andersen, Morten, Berg, Christian, Bishop, Iain, Burkhardt, Thomas, Garuoliene, Kristina, Herholz, Harald, Joppi, Roberta, Kalaba, Marija, Laius, Ott, Lonsdale, Julie, Malmström, Rickard E., Martikainen, Jaana E., Samaluk, Vita, Sermet, Catherine, Schwabe, Ulrich, Teixeira, Inês, Tilson, Lesley, Tulunay, F. Cankat, Vlahović-Palčevski, Vera, Wendykowska, Kamila, Wettermark, Bjorn, Zara, Corinne, Gustafsson, Lars L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153015/
https://www.ncbi.nlm.nih.gov/pubmed/21833180
http://dx.doi.org/10.3389/fphar.2010.00141
_version_ 1782209832132018176
author Godman, Brian
Shrank, William
Andersen, Morten
Berg, Christian
Bishop, Iain
Burkhardt, Thomas
Garuoliene, Kristina
Herholz, Harald
Joppi, Roberta
Kalaba, Marija
Laius, Ott
Lonsdale, Julie
Malmström, Rickard E.
Martikainen, Jaana E.
Samaluk, Vita
Sermet, Catherine
Schwabe, Ulrich
Teixeira, Inês
Tilson, Lesley
Tulunay, F. Cankat
Vlahović-Palčevski, Vera
Wendykowska, Kamila
Wettermark, Bjorn
Zara, Corinne
Gustafsson, Lars L.
author_facet Godman, Brian
Shrank, William
Andersen, Morten
Berg, Christian
Bishop, Iain
Burkhardt, Thomas
Garuoliene, Kristina
Herholz, Harald
Joppi, Roberta
Kalaba, Marija
Laius, Ott
Lonsdale, Julie
Malmström, Rickard E.
Martikainen, Jaana E.
Samaluk, Vita
Sermet, Catherine
Schwabe, Ulrich
Teixeira, Inês
Tilson, Lesley
Tulunay, F. Cankat
Vlahović-Palčevski, Vera
Wendykowska, Kamila
Wettermark, Bjorn
Zara, Corinne
Gustafsson, Lars L.
author_sort Godman, Brian
collection PubMed
description Introduction: European countries need to learn from each other to address unsustainable increases in pharmaceutical expenditures. Objective: To assess the influence of the many supply and demand-side initiatives introduced across Europe to enhance prescribing efficiency in ambulatory care. As a result provide future guidance to countries. Methods: Cross national retrospective observational study of utilization (DDDs – defined daily doses) and expenditure (Euros and local currency) of proton pump inhibitors (PPIs) and statins among 19 European countries and regions principally from 2001 to 2007. Demand-side measures categorized under the “4Es” – education engineering, economics, and enforcement. Results: Instigating supply side initiatives to lower the price of generics combined with demand-side measures to enhance their prescribing is important to maximize prescribing efficiency. Just addressing one component will limit potential efficiency gains. The influence of demand-side reforms appears additive, with multiple initiatives typically having a greater influence on increasing prescribing efficiency than single measures apart from potentially “enforcement.” There are also appreciable differences in expenditure (€/1000 inhabitants/year) between countries. Countries that have not introduced multiple demand side measures to counteract commercial pressures to enhance the prescribing of generics have seen considerably higher expenditures than those that have instigated a range of measures. Conclusions: There are considerable opportunities for European countries to enhance their prescribing efficiency, with countries already learning from each other. The 4E methodology allows European countries to concisely capture the range of current demand-side measures and plan for the future knowing that initiatives can be additive to further enhance their prescribing efficiency.
format Online
Article
Text
id pubmed-3153015
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-31530152011-08-10 Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications Godman, Brian Shrank, William Andersen, Morten Berg, Christian Bishop, Iain Burkhardt, Thomas Garuoliene, Kristina Herholz, Harald Joppi, Roberta Kalaba, Marija Laius, Ott Lonsdale, Julie Malmström, Rickard E. Martikainen, Jaana E. Samaluk, Vita Sermet, Catherine Schwabe, Ulrich Teixeira, Inês Tilson, Lesley Tulunay, F. Cankat Vlahović-Palčevski, Vera Wendykowska, Kamila Wettermark, Bjorn Zara, Corinne Gustafsson, Lars L. Front Pharmacol Pharmacology Introduction: European countries need to learn from each other to address unsustainable increases in pharmaceutical expenditures. Objective: To assess the influence of the many supply and demand-side initiatives introduced across Europe to enhance prescribing efficiency in ambulatory care. As a result provide future guidance to countries. Methods: Cross national retrospective observational study of utilization (DDDs – defined daily doses) and expenditure (Euros and local currency) of proton pump inhibitors (PPIs) and statins among 19 European countries and regions principally from 2001 to 2007. Demand-side measures categorized under the “4Es” – education engineering, economics, and enforcement. Results: Instigating supply side initiatives to lower the price of generics combined with demand-side measures to enhance their prescribing is important to maximize prescribing efficiency. Just addressing one component will limit potential efficiency gains. The influence of demand-side reforms appears additive, with multiple initiatives typically having a greater influence on increasing prescribing efficiency than single measures apart from potentially “enforcement.” There are also appreciable differences in expenditure (€/1000 inhabitants/year) between countries. Countries that have not introduced multiple demand side measures to counteract commercial pressures to enhance the prescribing of generics have seen considerably higher expenditures than those that have instigated a range of measures. Conclusions: There are considerable opportunities for European countries to enhance their prescribing efficiency, with countries already learning from each other. The 4E methodology allows European countries to concisely capture the range of current demand-side measures and plan for the future knowing that initiatives can be additive to further enhance their prescribing efficiency. Frontiers Research Foundation 2011-01-07 /pmc/articles/PMC3153015/ /pubmed/21833180 http://dx.doi.org/10.3389/fphar.2010.00141 Text en Copyright © 2011 Godman, Shrank, Andersen, Berg, Bishop, Burkhardt, Garuoliene, Herholz, Joppi, Kalaba, Laius, Lonsdale, Malmström, Martikainen, Samaluk, Sermet, Schwabe, Teixeira, Tilson, Tulunay, Vlahović-Palčevski, Wendykowska, Wettermark, Zara and Gustafsson. http://www.frontiersin.org/licenseagreement This is an open-access article subject to an exclusive license agreement between the authors and the Frontiers Research Foundation, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
spellingShingle Pharmacology
Godman, Brian
Shrank, William
Andersen, Morten
Berg, Christian
Bishop, Iain
Burkhardt, Thomas
Garuoliene, Kristina
Herholz, Harald
Joppi, Roberta
Kalaba, Marija
Laius, Ott
Lonsdale, Julie
Malmström, Rickard E.
Martikainen, Jaana E.
Samaluk, Vita
Sermet, Catherine
Schwabe, Ulrich
Teixeira, Inês
Tilson, Lesley
Tulunay, F. Cankat
Vlahović-Palčevski, Vera
Wendykowska, Kamila
Wettermark, Bjorn
Zara, Corinne
Gustafsson, Lars L.
Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
title Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
title_full Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
title_fullStr Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
title_full_unstemmed Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
title_short Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
title_sort policies to enhance prescribing efficiency in europe: findings and future implications
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153015/
https://www.ncbi.nlm.nih.gov/pubmed/21833180
http://dx.doi.org/10.3389/fphar.2010.00141
work_keys_str_mv AT godmanbrian policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT shrankwilliam policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT andersenmorten policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT bergchristian policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT bishopiain policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT burkhardtthomas policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT garuolienekristina policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT herholzharald policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT joppiroberta policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT kalabamarija policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT laiusott policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT lonsdalejulie policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT malmstromrickarde policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT martikainenjaanae policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT samalukvita policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT sermetcatherine policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT schwabeulrich policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT teixeiraines policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT tilsonlesley policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT tulunayfcankat policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT vlahovicpalcevskivera policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT wendykowskakamila policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT wettermarkbjorn policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT zaracorinne policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications
AT gustafssonlarsl policiestoenhanceprescribingefficiencyineuropefindingsandfutureimplications